ClinConnect ClinConnect Logo
Search / Trial NCT06596408

Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .

Launched by SOHAG UNIVERSITY · Sep 11, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the blood vessels in the macula, which is the part of the eye responsible for central vision, in people with high myopia (nearsightedness) who do not have any severe eye problems related to their condition. The researchers are using a special imaging technique called Optical Coherence Tomography Angiography (OCTA) to look closely at these blood vessels. The goal is to better understand how high myopia affects the macular blood flow, which could help improve care for patients with this eye condition.

To participate in this study, you must be an adult with high myopia, meaning your eyesight is quite poor (specifically, a refractive error of -6 or worse). However, if you have any other eye diseases, a history of eye surgery or injury, or specific severe conditions related to myopia, you won’t be eligible. Participants will visit an outpatient clinic, where they will undergo the OCTA imaging. This study is currently recruiting and welcomes individuals of all genders, aged 18 and older. If you're interested, it could be a great opportunity to contribute to important research in eye health!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria wil include :
  • All myopic patients with axial high myopia (-6 spherical refractive error or more) of different age groups .
  • Exclusion Criteria will include :
  • -History of other any ocular diseases , systemic diseases that may affect the ocular circulation .
  • Previous intraocular surgery or ocular injury .
  • Any patient with pathological myopic maculopathy as epiretinal membrane, foveoschisis, macular holes, lamellar holes, Lacquers cracks, choroidal neovascularization and retinal atrophy .

About Sohag University

Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.

Locations

Sohag, , Egypt

Patients applied

0 patients applied

Trial Officials

Adham Salah Mohammed, lecturer

Study Chair

Sohag University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported